Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 8/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 3/20 | 0.34 |
| ▸ | MTOR | P42345 | 2/20 | 0.33 |
| ▸ | RIPK2 | O43353 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3846114 | 0.81 | RIPK2 (0.41) | KCNH2TGFBR1PIK3CAFLT3MTOR | |
| SCHEMBL3849695 | 0.80 | TGFBR1 (0.37) | KCNH2TGFBR1PIK3CACHEK1ATR | |
| Hydrochloric Acid SCHEMBL3847203 | 0.77 | KCNH2 (0.46) | KCNH2TGFBR1PIK3CACHEK1FLT3 | |
| Hydrochloric Acid SCHEMBL3847648 | 0.74 | MAPT (0.48) | TGFBR1 | |
| Hydrochloric Acid SCHEMBL3847228 | 0.73 | ALDH1A1 (0.42) | KCNH2FLT3 | |
| Hydrochloric Acid SCHEMBL5854209 | 0.69 | ALDH1A1 (0.43) | TGFBR1 | |
| Hydrochloric Acid SCHEMBL3856334 | 0.69 | FLT3 (0.48) | KCNH2TGFBR1FLT3 | |
| SCHEMBL13874250 | 0.66 | KCNH2 (0.40) | KCNH2PIK3CAFLT3MTORRIPK2 | |
| SCHEMBL3850435 | 0.65 | LMNA (0.44) | — | |
| Hydrochloric Acid SCHEMBL3846588 | 0.65 | FLT3 (0.56) | KCNH2TGFBR1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |